High-throughput, automated analysis of viral vector titer and process related impurities accelerates downstream process development of AAV based gene therapies
Viral vector production is a labor and resource-intensive process that often results in small batches of highly valuable product. Quantification of titer and impurities levels are important critical quality attributes that can consume a lot of sample and take considerable time to perform.
Download the poster to learn how AAV titer and three different impurities assays were performed in one single run on Gyrolab xPand requiring minimal hands-on time and sample volume.
If you have problems to download the poster please contact firstname.lastname@example.org